AU8336001A - Methods for diagnosis and therapy of hematological and virus-associated malignancies - Google Patents

Methods for diagnosis and therapy of hematological and virus-associated malignancies

Info

Publication number
AU8336001A
AU8336001A AU8336001A AU8336001A AU8336001A AU 8336001 A AU8336001 A AU 8336001A AU 8336001 A AU8336001 A AU 8336001A AU 8336001 A AU8336001 A AU 8336001A AU 8336001 A AU8336001 A AU 8336001A
Authority
AU
Australia
Prior art keywords
hematological
virus
diagnosis
therapy
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8336001A
Inventor
Alexander Gaiger
Martin A Cheever
Susan Hand-Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US63828000A priority Critical
Priority to US67590400A priority
Application filed by Corixa Corp filed Critical Corixa Corp
Priority to PCT/US2001/025408 priority patent/WO2002013847A2/en
Publication of AU8336001A publication Critical patent/AU8336001A/en
Application status is Pending legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
AU8336001A 2000-08-14 2001-08-13 Methods for diagnosis and therapy of hematological and virus-associated malignancies Pending AU8336001A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US63828000A true 2000-08-14 2000-08-14
US67590400A true 2000-09-28 2000-09-28
PCT/US2001/025408 WO2002013847A2 (en) 2000-08-14 2001-08-13 Methods for diagnosis and therapy of hematological and virus-associated malignancies

Publications (1)

Publication Number Publication Date
AU8336001A true AU8336001A (en) 2002-02-25

Family

ID=27093044

Family Applications (1)

Application Number Title Priority Date Filing Date
AU8336001A Pending AU8336001A (en) 2000-08-14 2001-08-13 Methods for diagnosis and therapy of hematological and virus-associated malignancies

Country Status (2)

Country Link
AU (1) AU8336001A (en)
WO (1) WO2002013847A2 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282365B2 (en) 2003-01-03 2007-10-16 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Rhesus HER2/neu, nucleotides encoding same, and uses thereof
CN103394083B (en) 2003-11-06 2017-07-18 西雅图基因公司 Monomethyl valine compound that can be with ligand coupling
CN102973947A (en) 2004-06-01 2013-03-20 健泰科生物技术公司 Antibody-drug conjugates and methods
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
ES2579805T3 (en) 2004-09-23 2016-08-16 Genentech, Inc. Antibodies and conjugates engineered with cysteine
EP2475391B1 (en) 2009-09-09 2018-09-12 Centrose, LLC Extracellular targeted drug conjugates
RS52983B (en) 2010-04-15 2014-02-28 Spirogen Sárl Pyrrolobenzodiazepines and conjugates thereof
SG10201600791TA (en) 2010-06-08 2016-03-30 Genentech Inc Cysteine engineered antibodies and conjugates
CN103313990B (en) 2010-11-17 2016-07-20 基因泰克公司 Alanyl maytansinol antibody coupling matter
ES2567276T3 (en) 2011-05-12 2016-04-21 Genentech, Inc. LC-MS / MS method of monitoring multiple reactions to detect therapeutic antibodies in animal samples using frame-changing peptides
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
SI2906298T1 (en) 2012-10-12 2018-12-31 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
KR101995621B1 (en) 2012-10-12 2019-07-03 에이디씨 테라퓨틱스 에스에이 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
DK2766048T3 (en) 2012-10-12 2015-03-02 Spirogen Sarl Pyrrolobenzodiazepins and conjugates thereof
LT2906296T (en) 2012-10-12 2018-06-11 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
CA2894961A1 (en) 2012-12-21 2014-06-26 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
CN105246894A (en) 2012-12-21 2016-01-13 斯皮罗根有限公司 Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
AU2014229529B2 (en) 2013-03-13 2018-02-15 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
NZ710745A (en) 2013-03-13 2019-03-29 Genentech Inc Pyrrolobenzodiazepines and conjugates thereof
ES2687439T3 (en) 2013-03-13 2018-10-25 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
JP2016530254A (en) 2013-08-12 2016-09-29 ジェネンテック, インコーポレイテッド 1- (Chloromethyl) -2,3-dihydro-1H-benzo [E] indole dimer antibody-drug conjugate compound and methods of use and treatment
EP3082876B1 (en) 2013-12-16 2018-01-17 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054983B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
US9950078B2 (en) 2013-10-11 2018-04-24 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
KR20160094981A (en) 2013-12-16 2016-08-10 제넨테크, 인크. Peptidomimetic compounds and antibody-drug conjugates thereof
CA2933557A1 (en) 2013-12-16 2015-06-25 Genentech, Inc. Peptidomimetic compounds and antibody-drug conjugates thereof
CN106687141A (en) 2014-09-10 2017-05-17 麦迪穆有限责任公司 Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
AU2015314826A1 (en) 2014-09-12 2017-03-02 Genentech, Inc. Cysteine engineered antibodies and conjugates
WO2016040825A1 (en) 2014-09-12 2016-03-17 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
EP3235820A1 (en) 2014-09-17 2017-10-25 Genentech, Inc. Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
KR20170086121A (en) 2014-12-03 2017-07-25 제넨테크, 인크. Quaternary amine compounds and antibody-drug conjugates thereof
AR106235A1 (en) 2015-10-02 2017-12-27 Genentech Inc Conjugates of antibody-drug and methods of use pirrolobenzodiazepina
JP2018537416A (en) 2015-10-16 2018-12-20 ジェネンテック, インコーポレイテッド Constrained disulfide drug conjugate
WO2017068511A1 (en) 2015-10-20 2017-04-27 Genentech, Inc. Calicheamicin-antibody-drug conjugates and methods of use
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
EP3433621A1 (en) 2016-03-25 2019-01-30 H. Hoffnabb-La Roche Ag Multiplexed total antibody and antibody-conjugated drug quantification assay
EP3458101A1 (en) 2016-05-20 2019-03-27 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
US20170370906A1 (en) 2016-05-27 2017-12-28 Genentech, Inc. Bioanalytical analysis of site-specific antibody drug conjugates
US20170348422A1 (en) 2016-06-06 2017-12-07 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
EP3496763A1 (en) 2016-08-11 2019-06-19 Genentech, Inc. Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
WO2018065501A1 (en) 2016-10-05 2018-04-12 F. Hoffmann-La Roche Ag Methods for preparing antibody drug conjugates
WO2019060398A1 (en) 2017-09-20 2019-03-28 Ph Pharma Co., Ltd. Thailanstatin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
EP0711565B1 (en) * 1994-11-10 1998-08-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum Inhibiting growth of leukemic cells by targeting HER-2 protein
EP1214595A2 (en) * 1999-09-22 2002-06-19 Corixa Corporation Methods for diagnosis and therapy of hematological and virus-associated malignancies

Also Published As

Publication number Publication date
WO2002013847A2 (en) 2002-02-21
WO2002013847A3 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides
GB2366643B (en) Methods of compressing instructions for processors
DE60123988D1 (en) Methods and preparations for tissue regeneration
GB2367469B (en) Software definable pre-amplifier
EP1089724A4 (en) Therapeutic compositions and methods of use
AU4576701A (en) Continuous localization and guided treatment of cardiac arrhythmias
IL162483D0 (en) Hyperthermia treatment and probe therefor
AU1169702A (en) Non-invasive enzyme screen for tissue remodelling-associated conditions
PL366575A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
HK1126379A1 (en) Mri guided hyperthermia surgery
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
AU7494401A (en) Method and assembly for lung volume reduction
AU1695502A (en) Polyfunctional organosilane for use as coupling agent and method for obtaining same
HK1059208A1 (en) System for tissue treatment
AU2585502A (en) Preparation of nanocrystallites
PL362597A1 (en) Improved protection tampon and method of making
AU6483501A (en) Polymerizable compositions and methods of use
AU8846201A (en) Medical instrument
HU0303555A3 (en) Hydrolysis of [r(r
AU5312601A (en) (+) naloxone and epinephrine combination therapy
AU6826301A (en) Surgical cable assembly and method
AU6529601A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU6683301A (en) Method and system for limiting the use of user-specific software features
AU2002220041A1 (en) System and method for tissue treatment
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer